TRIESENCE

Product NDC: 0078-0897
11-digit product format: 000780897
Labeler code: 0078
Product ID: 0078-0897_4e6e468e-47e6-3f48-e063-6294a90a035d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: triamcinolone acetonide
Dosage form: INJECTION, SUSPENSION
Route: OPHTHALMIC
Labeler: Novartis Pharmaceuticals Corporation
Application: NDA022048
Marketing category: NDA
Marketing start: 2024-10-01
Substance: TRIAMCINOLONE ACETONIDE
Active strength: 40 mg/mL
Pharmacologic classes: Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N022048-001	TRIESENCE	TRIAMCINOLONE ACETONIDE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL		RLD, RS	2007-11-29

Orange Book patents#

Current patent rows page 1 of 1 · 3 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N022048-001	8211880	2029-03-10	U-1257		2012-08-06
N022048-001	8211880	2029-03-10	U-1258		2012-08-06
N022048-001	8128960	2029-12-17		Drug product

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N022048-001	TRIESENCE	40MG/ML (40MG/ML)	INJECTABLE / INTRAVITREAL	RLD, RS	2007-11-29	`cb3db0bc1861…`

Observed Orange Book patent history#

Patent history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022048-001	8211880	2029-03-10	U-1257		2012-08-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N022048-001	8128960	2029-12-17		Drug product		`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022048-001	8211880	2029-03-10	U-1257		2012-08-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N022048-001	8128960	2029-12-17		Drug product		`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022048-001	8211880	2029-03-10	U-1257		2012-08-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N022048-001	8128960	2029-12-17		Drug product		`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022048-001	8211880	2029-03-10	U-1257		2012-08-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N022048-001	8128960	2029-12-17		Drug product		`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022048-001	8211880	2029-03-10	U-1257		2012-08-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N022048-001	8128960	2029-12-17		Drug product		`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022048-001	8211880	2029-03-10	U-1257		2012-08-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N022048-001	8128960	2029-12-17		Drug product		`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022048-001	8211880	2029-03-10	U-1257		2012-08-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N022048-001	8128960	2029-12-17		Drug product		`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022048-001	8211880	2029-03-10	U-1257		2012-08-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N022048-001	8128960	2029-12-17		Drug product		`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022048-001	8211880	2029-03-10	U-1257		2012-08-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N022048-001	8128960	2029-12-17		Drug product		`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022048-001	8211880	2029-03-10	U-1257		2012-08-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N022048-001	8128960	2029-12-17		Drug product		`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022048-001	8211880	2029-03-10	U-1257		2012-08-06	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N022048-001	8128960	2029-12-17		Drug product		`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022048-001	8211880	2029-03-10	U-1257		2012-08-06	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N022048-001	8128960	2029-12-17		Drug product		`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022048-001	8211880	2029-03-10	U-1257		2012-08-06	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N022048-001	8128960	2029-12-17		Drug product		`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N022048-001	8211880	2029-03-10	U-1258		2012-08-06	`8072bd15b7f6…`

Additional Listing Data#

Finished product: Yes
Brand name base: TRIESENCE
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
TRIAMCINOLONE ACETONIDE	40 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
F446C597KA	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1086259	Internal RxNorm lookup
1792144	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
22692d92-1359-9252-e063-6394a90ab669	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d4d7da1a-7fd4-628e-cdae-89e749b1c534	Product name	7	20260127
9e37788c-b1bf-42ae-aac9-b60601606144	Product name	8	20260122
75f7e47b-8736-a182-fc44-22aca8d79689	Product name	2	20251211
62986c8d-91f1-b1ba-b5a3-8b54b75bb8c2	Product name	6	20250516
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2	Product name	5	20250304
1527ac37-808d-43be-a63e-74e1258dbe46	Product name	9	20250219
bed0530e-f939-4541-956b-6928a2f6404f	Product name	1	20241008
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	6	20240814
e42f429b-c4e5-0402-e1c5-730154df4060	Product name	4	20240205
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
9fcb7a91-de07-4f00-aabf-e4d6fda403d5	Product name	8	20230322
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
38d4de13-64b3-4057-b91c-4b5126962341	Product name	1	20220516
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
9badc7be-250a-44ab-aa36-926af3f02679	Product name	1	20210527
089e0644-1ea8-8654-4113-39f960dd57d5	Product name	3	20210115
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
0ec3537a-6c9b-432a-896c-b9ea8723049a	Product name	9	20200701
1629e00f-54fb-4a43-8306-b58442b23902	Product name	9	20200430
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
5331c9c8-f64b-11e6-ccf1-071c477fcb0b	Product name	7	20190612
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
7916de40-e296-41f0-b811-6d0df1a33e2c	Product name	9	20180627
cefa60e2-a5b5-493e-9c54-24735b7dc509	Product name	2	20171212
9f64e0dc-109c-9660-8e0e-91ec987b3817	Product name	6	20171204
dfa879a3-32de-49f0-a7ba-9b9c3e13002f	Product name	1	20171204
8de20f81-8411-4cf1-a8b2-03404ee56d01	Product name	3	20171109
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
a5f1a68c-0352-4f34-46a3-9b4eed239ed8	Product name	2	20160819
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
355b2224-0895-7135-83f5-d099a6a82a0a	Product name	1	20140508
55be6b50-8cc0-f0f1-74a1-3416a91193aa	Product name	1	20140508
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
7a0092d1-1e8c-0d78-4f8d-d95fa15cc3cf	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
89b93c13-4be8-69f3-b33b-63e64feffb9b	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0078-0897-78	2026-01-29	C162847	48780-1	49896155-a7a1-586f-e063-e6dba90add90	These highlights do not include all the information needed to use TRIESENCE (triamcinolone acetonide injectable suspension) 40 mg/mL safely and effectively. See full prescribing information for TRIESENCE suspension. TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL Initial U.S. Approval: 1957

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0078-0897-78	TRIESENCE	1 in 1 BLISTER PACK	INJECTION, SUSPENSION	1		2
0078-0897-78	TRIESENCE	1 in 1 CARTON	INJECTION, SUSPENSION	1		2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0078-0897-78	ML - Milliliter	0078-0897	a3f6dabe-399d-425c-82e8-b98fd3892306	1	2024-11-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0078-0897	TRIESENCE (TRIAMCINOLONE ACETONIDE) INJECTION, SUSPENSION [NOVARTIS PHARMACEUTICALS CORPORATION]	1	Current NDC, 2 package rows	20241001_22692d92-1359-9252-e063-6394a90ab669.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TRIESENCE	TRIAMCINOLONE ACETONIDE	Harrow Eye, LLC	2267978c-72ad-9229-e063-6394a90a09d0	2026-06-05	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022048 application number: NDA022048
TRIESENCE	TRIAMCINOLONE ACETONIDE	Novartis Pharmaceuticals Corporation	22692d92-1359-9252-e063-6394a90ab669	2026-04-01	Warnings, Adverse reactions	Exact identifier application applno (NDA): 022048 application number: NDA022048 ndc (product): 0078-0897

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
F446C597KA	TRIAMCINOLONE ACETONIDE	76-25-5	TRIAMCINOLONE ACETONIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1792144	triamcinolone acetonide 40 MG in 1 ML Injection	PSN	22692d92-1359-9252-e063-6394a90ab669	2
1086259	Triesence 40 MG in 1 ML Injection	PSN	22692d92-1359-9252-e063-6394a90ab669	2
1086259	1 ML triamcinolone acetonide 40 MG/ML Injection [Triesence]	SBD	22692d92-1359-9252-e063-6394a90ab669	2
1792144	1 ML triamcinolone acetonide 40 MG/ML Injection	SCD	22692d92-1359-9252-e063-6394a90ab669	2
1086259	1 ML Triesence 40 MG/ML Injection	SY	22692d92-1359-9252-e063-6394a90ab669	2
1792144	triamcinolone acetonide 40 MG per 1 ML Injection	SY	22692d92-1359-9252-e063-6394a90ab669	2
1086259	Triesence 40 MG per 1 ML Injection	SY	22692d92-1359-9252-e063-6394a90ab669	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
0078-0897-78	00078089778	1 BLISTER PACK in 1 CARTON (0078-0897-78) / 1 VIAL, GLASS in 1 BLISTER PACK / 1 mL in 1 VIAL, GLASS	1 blister pack	2024-10-01	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
TRIESENCE	Novartis Pharmaceuticals Corporation \| Alcon Research LLC	2026-04-01	HUMAN PRESCRIPTION DRUG LABEL	2